Kepos Capital’s BiomX PHGE Stock Holding History

Kepos Capital’s Portfolio PHGE Stock Details PHGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,372	Closed	-$870K	–	553
2022 Q1	$870K	Hold	2,372	–	–	0.07%	182
2021 Q4	$721K	Hold	2,372	–	–	0.06%	231
2021 Q3	$1.38M	Buy	+2,372	New	+$1.84M	0.09%	270

Other funds holding PHGE

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Kepos Capital's PHGE Position: Q2 2022 in Review

Kepos Capital sold out of BiomX (PHGE) in Q2 2022, closing a stake of 2,372 shares — an estimated $870K sold.

Kepos Capital first reported a position in PHGE in Q3 2021 and held it in 3 quarters. The position peaked at $1.38M in Q3 2021. 10 funds tracked by Wall St. Rank hold PHGE as of Q2 2022.

Kepos Capital reported no remaining BiomX position as of Q2 2022 after selling out during the quarter.
Kepos Capital sold 2,372 BiomX shares in Q2 2022, an estimated $870K.
Kepos Capital first reported a position in BiomX in Q3 2021 and held it in 3 quarters.
Kepos Capital's BiomX position peaked at $1.38M in Q3 2021.
10 funds tracked by Wall St. Rank held BiomX as of Q2 2022.

Based on Kepos Capital's 13F filing for Q2 2022, filed 12 Aug 2022.